Tag Archives: ONCE

Crispr Therapeutics: Assessing The Recent Capital Financing

The reason why the growth stocks do so much better is that they seem to show gains in value in the hundreds of percent each decade. In contrast, it is an unusual bargain that is as much as 50 percent undervalued. The cumulative effect of this simple arithmetic should be obvious. – Philip Fisher (the Father of Growth Investing)

On Jan 05, 2018, the share price of Crispr Therapeutics (NASDAQ:CRSP), a bioscience focusing on gene-editing and CAR-T to treat serious conditions such as cancers and genetic diseases, continued its rally. The stock added another $2.90 (over 12% profits) to value at $26.81 for the said trading session. Since we recommended the company on Nov. 27, 2017 (just over a month) to subscribers of Integrated BioSci Investing, the stock added another $7.26 (or 37% in capital appreciation). This robust run-up is interesting because, on Jan. 04, 2018, the company announced that the 5M additional common shares issued on Jan 03 will be priced at $22.75.

Figure 1: Crispr stock chart. (Source: Stockcharts).

At Integrated BioSci Investing (IBI), we have much success in finding robust performers. For instance, Nektar Therapeutics (NASDAQ:NKTR) appreciated over 200% for subscribers. Exelixis Inc procured over 50% profits. In this report, we’ll assess the ramifications of the recent financing and to reaffirm the investment thesis on Crispr.

Fundamentals Analysis

Back in 2017, there were several stellar medical breakthroughs that have ramifications that can be as far reaching as the introduction of chemotherapy more than a decade prior. Accordingly, the US FDA approved Yescarta (a CAR-T indicated for the treatment of non-Hodgkin lymphoma). The said molecule was innovated by Kite Pharma (NASDAQ:KITE) – a firm acquired by Gilead Sciences(NASDAQ:GILD). Moreover, the agency also approved the first gene therapy, Luxturna (voretigene neparvovec-rzyl), a molecule innovated by Sparks Therapeutics (NASDAQ:ONCE). It is a one-time treatment for patients afflicted with biallelic RPE65 mutation-associated retinal dystrophy.

In the midst of the aforesaid favorable regulatory environment for medical breakthroughs, the Switzerland-based company, Crispr Therapeutics is also brewing a revolutionary method of treating cancers and rare genetic diseases. As follows, CRISPR/Cas9 is a form of gene-editing currently being investigated in various conditions (as shown in the enriched pipeline in figure 2). The company also has a gene-editing enhanced form of CAR-T in development for various cancers. Of most interest is the lead molecule, CTX-001 (also a gene-editing therapeutic) that can be potentially used for the management of serious blood disorders: beta-thalassemia and sickle cell disease (SCD).

Figure 2: Therapeutic pipeline. (Source: Crispr).

Final Remarks

As alluded, Crispr recently issued another 5M common shares at the price of $22.75. The company also granted the underwriters a 30-day option to purchase up to 750K of its common shares. The expected gross proceeds from this offering are roughly $113.75M (excluding any exercise of the underwriters option to purchase additional shares). Moreover, the offering is expected to close on Jan. 09. The company employed Goldman Sachs (NYSE:GS), Piper Jaffray (NYSE:PJC), Barclays Capital (NYSE:BCS), and Guggenheim Securities as joint book-running managers for the said offerings. We strongly believe that the aforesaid capital financing is both strategic and prudent, as substantial capital (in the ballpark of over a billion dollars) is needed to fund a molecule from bench research to commercialization. With the share price appreciating, it is wise that the firm issued new shares to strengthen its capital for further pipeline innovation. There is an in-depth Integrated BioSci version of this research, which is available in advanced to subscribers of Integrated BioSci Investing.

Authors Notes: Were honored that you took the time out of your busy day to read our market intelligence. Founded by Dr. Hung Tran, MD, MS, CNPR, (in collaborations with Dr. Tran BioSci analyst, Ngoc Vu, and other PhDs), Integrated BioSci Investing (IBI) marketplace research is delivering stellar returns since inceptions. To name a few, Nektar Therapeutics (NASDAQ:NKTR) procured more than 210% profits; Spectrum Pharmaceuticals (NASDAQ:SPPI) delivered over 180% gains; Kite Pharma netted 82%. Exelixis Inc (NASDAQ:EXEL) earned greater than 50% capital appreciation. Our secret sauce is extreme due diligence coupled with expert data analysis. The service features a once-weekly exclusive in-depth Integrated BioSci Alpha-Intelligence article (in the form of research, reports, or interviews), daily individual stocks consulting, and model portfolios.

Notably, well increase our price soon. SUBSCRIBE to our marketplace research now to lock in the legacy price and save money in the future. To receive real-time alerts on our articles as well as blogs, be sure to check out our profile page and CLICK the orange FOLLOW button . Asides the exclusivities, this article is the truncated version of the research we published in advance to IBI subscribers. Further, you can read up on Dr. Trans background by following this link.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:ExpandAuthor payment: Seeking Alpha pays for exclusive articles. Payment calculations are based on a combination of coverage area, popularity and quality.Tagged: Investing Ideas, Long Ideas, Healthcare, Biotechnology, SwitzerlandWant to share your opinion on this article? Add a comment.Disagree with this article? Submit your own.To report a factual error in this article, click here

Top Stocks To Watch For 2018

Large cap upscale accessories retailer Coach Inc (NYSE: COH) reported FY17 Q4 and year end earnings before the market opened on Tuesday with shares falling off in premarket trading despite profit doubling. Q4 net sales totaled $1.13 billion versus $1.15 billion in the prior year. Excluding the additional week included in fiscal 2016 results, net sales increased 6% on a reported basis and 7% on a constant currency basis. The earnings release noted that as planned, the Companys strategic decision to elevate the Coach brands positioning in the North American wholesale channel through a reduction in promotional events and door closures negatively impacted sales growth by approximately 60 basis points in the quarter. Net income was $152 million versus net income of $82 million.

For fiscal year 2017, net sales totaled $4.49 billion versus $4.49 billion in the prior year. Excluding the additional week included in fiscal 2016 results, net sales increased 2% on both a reported and constant currency basis. Net income totaled $591 million on a reported basis versus reported net income of $461 million.

Top Stocks To Watch For 2018: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the month, LogMeIn announced the completion of its merger with Citrix Systems, Inc (NASDAQ: CTXS) GetGo, Inc subsidiary.

    In late October, LogMeIn reported 22% third quarter revenue growth to $85.1 million and GAAP net loss was $0.7 million compared to a GAAP net income of $5.6 million. LogMeIn will report its fourth quarter and fiscal year 2016 financial results for the period ended December 31, 2016 following the close of market on February 28.

  • [By Ben Levisohn]

    Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

  • [By Ben Levisohn]

    Citrix Systems (CTXS)soared nearly to the top of the S&P 500 today afterreports it had hired Goldman Sachs (GS) to pursue a sale of the company.

    S. MARTIN/AFP/Getty Images

    Citrix Systemsgained 6.8% to $84.93 today, while the S&P 500 finished little changed at 2,373.47.

    Business Insider’s Matt Weinbergerhas the details:

    Citrix, the $13 billion tech company best known for software like GoToMeeting, is working with Goldman Sachs to negotiate a possible sale, reports Bloomberg, citing anonymous sources.

    This isn’t the first time that Citrix has shopped itself around: in late 2015, and under pressure from activist shareholder Elliott Management, Citrix was said to have unsuccessfully tried to find a buyer.

    Citrix Systems market cap rose t0 $13.3 billion today from $12.4 billion on Friday. It reported net income of $536 million on sales of $3.4 billion in 2016.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Citrix Systems, Inc. (NASDAQ: CTXS) which jumped 6.8% to $84.93. The stocks 52-week range is $59.72 to $87.99. Volume was 5.19 million which is well above the daily average of around 2.09 million shares.

Top Stocks To Watch For 2018: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

Top Stocks To Watch For 2018: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Four ideas turned up in this screen that might be of interest (prices as of February 9th close):

    Heron Therapeutics (NASDAQ:HRTX) by ONeil Trader – published February 3rd, 2017, $525M Market cap, down ~2% since publication, author’s price target offers 130% upside. HRTX isn’t a generic drug provider, but its CINV franchise vs. the growth of a new drug gives it a similar sort of profile, and arguably a favorable risk/reward; commenters were mostly positive on the thesis. VistaGen Therapeutics (OTC:VTGN) by Logical Assessment – published July 29, 2016, $24M market cap, down 16% since publication, author’s price target offers 100%+ upside. This is obviously deeper into the speculative pile, but if the author’s thesis holds about VistaGen’s unique angle in the antidepressant drug space, comparable deals suggest good upside. (Of course, it’s always dangerous to rely solely on comparables). Dr. Reddy’s Laboratories (NYSE:RDY) by Buddy Lyons – published July 5, 2016, $7.6B market cap, down ~13% since publication, author’s price target offers just shy of 100% upside. Dr. Reddy’s is a more obvious comparable to TEVA, with a generics business but also a manufacturing business and a proprietary products branch. The company bought a divestiture package of drugs from TEVA as part of the Allergan/Actavis deal. A big overhang was an FDA warning letter; the FDA is due to reinspect facilities this month or next, which could resolve that one way or another. Lannett (NYSEMKT:LCI) by Lateral Capital Management – published May 27, 2016, $750M market cap, down ~9% since publication, author’s price target offers 75% upside. LCI’s trading had been 90% correlated with Valeant, but Lateral Capital Management argues that the correlation is unjustified. The article does a deep dive into the company’s valuation and credit risk, and was well received at the time, even if the market hasn’t agreed…yet.

    I also checked to see if there are any ideas starting to play out on the short si

  • [By Money Morning News Team]

    Consider one of the top penny stocks from December,VistaGen Therapeutics Inc.(Nasdaq: VTGN). VTGN shares soared 156% in a single day of trading on Dec. 6.

  • [By William Romov]

    VistaGen Therapeutics Inc. (Nasdaq: VTGN) is among the top penny stocks to watch this week after climbing 135% in just three trading sessions last week.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.02. Investors who bought at $2.55 are sitting on a 60% loss today (Dec. 18).

  • [By Money Morning Staff Reports]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up from $0.92 to $2.55 on Dec. 6. Since then, the stock pulled back to $1.07. Investors who bought at $2.55 are sitting on a 58% loss today (Jan. 8).

Top Stocks To Watch For 2018: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group peaking in early 2015 while peerSTMicroelectronics NV (NYSE: STM) hasnt performed much better and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) have performed better:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group giving investors and traders a bit of a roller-coaster ride while peerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX) really took off last year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group along with peersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)all taking offlast year albeit MRVL has underperformed ETF benchmarks:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group in an uptrend for the past two year, but also under performingpeerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX):

Top Stocks To Watch For 2018: ZIOPHARM Oncology Inc(ZIOP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

  • [By Paul Ausick]

    Ziopharm Oncology Inc. (NASDAQ: ZIOP) dropped more than 10% Tuesday to post a 52-week low of $3.77 after closing at $4.20 on Monday. The 52-week high is $7.88. Volume was around 3.7 million, more than double the daily average. The company reported Tuesday on progress of two platforms it is developing and investors did not like what they heard.

Top Stocks To Watch For 2018: Winnebago Industries Inc.(WGO)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Supply could come from any number of industry players, including Winnebago Industries, Inc. (NYSE: WGO), Thor Industries, Inc. (NYSE: THO), Polaris Industries Inc. (NYSE: PII) and Camping World Holdings Inc (NYSE: CWH). However, whether it comes from existing inventory and whether suppliers can meet the demand are yet to be seen.

  • [By Dan Caplinger]

    Friday was a good day on Wall Street, as the stock market responded favorably to encouraging news on the employment front. The U.S. unemployment rate dropped on fairly strong job creation during the month of February, and that helped push the Dow, S&P 500, and Nasdaq Composite to modest gains of roughly between a quarter percent and a half percent. Yet even with a positive mood among market participants, some stocks weren’t able to participate in the end-of-week rally. Finisar (NASDAQ:FNSR), Zumiez (NASDAQ:ZUMZ), and Winnebago Industries (NYSE:WGO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Peter Graham]

    The Q2 2017 earnings report for small cap motor home or RV stock Winnebago Industries, Inc (NYSE: WGO) is scheduled for before the market opens onWednesday (March 22nd). Back in2014, Winnebago Industries was in our SmallCap Network Elite Opportunity (SCN EO) portfolioas we believed the company would benefit from lower gas pricesalong with aBaby Boomer generation whos recreational retirement spending will increase. OurSCN EO newsletter noting at the time:

Top 10 Safest Stocks For 2018

We spoke with the company Nvidia (NASDAQ:NVDA) in late June and we fell in love all over again. As an analyst who lives and dies by working through the earnings model to figure out earnings numbers it doesn’t get much better than Nvidia. The Street has been low, is currently low, and probably is still very low on the coming quarters as well. On a simple PE valuation with no fancy numbers we’re about to show you how this stock can easily be another double from here in the next 12 months.

We Give Nvidia Our Official Highest Rating: Love

We love it.

Top 10 Safest Stocks For 2018: Jacobs Engineering Group Inc.(JEC)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Jacobs Engineering Group Inc. (NYSE: JEC) which rose about 9% to $64.92. The stocks 52-week range is $49.31 to $65.29. Volume was1.8 million compared to its average volume of less than 1 million.

  • [By Ben Levisohn]

    Lee offers 22 stocks that could benefit from the correlation trade: Western Digital (WDC), Xerox (XRX), First Solar, Ford Motor, Best Buy (BBY), PulteGroup (PHM), AutoNation (AN), Textron (TXT), Jacobs Engineering Group (JEC), Mosaic, BB&T (BBT), Fifth Third Bancorp (FITB),Loews (L), Regions Financial (RF), KeyCorp (KEY), Comerica (CMA), Leucadia National (LUK), Zions Bancorp (ZION), Valero Energy (VLO), Marathon Oil, Cardinal Health (CAH), and Pepco Holdings (POM).

Top 10 Safest Stocks For 2018: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    China Automotive Systems, Inc. (NASDAQ: CAAS) is projected to post its quarterly earnings at $0.20 per share on revenue of $108.22 million.

    Affimed NV (NASDAQ: AFMD) is projected to post a quarterly loss at $0.18 per share on revenue of $1.71 million.

Top 10 Safest Stocks For 2018: CenturyLink, Inc.(CTL)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Originally a rural telecom, CenturyLink (CTL) has grown via acquisitions to become a major provider of broadband, voice, video, and data.

    It now provides services residential and business customers over a 250,000-route-mile US fiber network and a 300,000 mile international network.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday CenturyLink, Inc. (NYSE: CTL) which rose over 8% to $15.88. The stocks 52-week range is $13.16 to $27.61. Volume was over 25 million compared to its average volume of 14.6 million.

  • [By Paul Ausick]

    CenturyLink Inc. (NYSE: CTL) dropped about 7.8% Monday to post a new 52-week low of $17.07 after closing at $18.51 on Friday. The 52-week high is $30.39. Volume was around 21 million, about double the daily average of around 11 million. The company’s $34 billion acquisition of Level 3 Communications received FCC approval, but the company was hit with a charge of securities fraud.

Top 10 Safest Stocks For 2018: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Lisa Levin] Related WFC Why Bank ETFs Fell On Friday Despite Decent Earnings Phil's Stock World: Funtime Friday Earnings Season Starts Today Rising Book Values and Margins of Safety (GuruFocus)
    Related C Earnings Preview: Financial Giants BAC, GS, And MS Report Q2 Results This Week Why Bank ETFs Fell On Friday Despite Decent Earnings Palo Capital, Inc. Buys Citigroup Inc, Schlumberger, NetApp Inc, Sells Citrix Systems Inc, … (GuruFocus) Companies Reporting Before The Bell
    Wells Fargo & Co (NYSE: WFC) is estimated to report quarterly earnings at $1.02 per share on revenue of $22.51 billion.
    Citigroup Inc (NYSE: C) is projected to report quarterly earnings at $1.26 per share on revenue of $17.71 billion.
    JPMorgan Chase & Co. (NYSE: JPM) is expected to report quarterly earnings at $1.65 per share on revenue of $25.61 billion.
    PNC Financial Services Group Inc (NYSE: PNC) is projected to report quarterly earnings at $2.02 per share on revenue of $4.00 billion.
    First Republic Bank (NYSE: FRC) is estimated to report quarterly earnings at $1.1 per share on revenue of $675.70 million.
    First Horizon National Corp (NYSE: FHN) is projected to report quarterly earnings at $0.28 per share on revenue of $337.89 million.

     

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.26 per share on revenue of $17.71 billion before the opening bell. Citigroup shares rose 0.30 percent to $67.22 in after-hours trading.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.65 per share on revenue of $25.61 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.48 percent to $93.55 in after-hours trading.
    Cyberark Software Ltd (NASDAQ: CYBR) lowered its guidance for the second quarter. The company now expects total revenue of $57.0 million to $57.5 million, versus earlier guidance of $61.0 million to $62.0 million. Cyberark shares dipped 17.65 percent to $42.00 in the after-hours trading session.
    Before the opening bell, First Republic Bank (NYSE: FRC) is projected to report quarterly earnings at $1.1 per share on revenue of $675.70 million. First Republic Bank shares dropped 0.80 percent to close at $101.35 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Safest Stocks For 2018: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

Top 10 Safest Stocks For 2018: Hanesbrands Inc.(HBI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 0.6% on Thursday to post a new 52-week low of $21.41 after closing at $21.53 on Wednesday. The stock’s 52-week high is $31.36. Volume was about a third the daily average of around 6 million shares. The company had no specific news Thursday.

  • [By Rich Duprey]

    If a stock falls hard, particularly one with a durable name in its industry, it could be an opportunity to pick up shares on the cheap. But sometimes, a stock trades at a discount for a very good reason, so let’s take a look at Whirlpool (NYSE:WHR), Hanesbrands (NYSE:HBI), and Vista Outdoor (NYSE:VSTO) to see if they are good values at these lower prices — or just value traps.

  • [By Paul Ausick]

    Hanesbrands Inc. (NYSE: HBI) dropped about 5.9% on Wednesday to post a new 52-week low of $21.50 after closing at $22.86 on Tuesday. The stock’s 52-week high is $31.36. Volume of about 31 million was more than 7 times the daily average of 4.5 million. The company had no specific news.

  • [By Ben Levisohn]

    Today, the Wall Street Journal reported that Kate Spade & Co is considering a sale of the company, following pressure from activist investors given the volatile performance ever since Kate Spade became a mono brand company over 2 years ago. The article cites thatKate Spade has hired an investment bank and has reached out to possible buyers (including other retailers) althoughKate Spade has not responded. This comes at a time when brand houses like VF Corp. (VFC), PVH Corp. (PVH), Hanesbrands (HBI), Michael Kors Holdings (KORS), and Coach have said they are looking to make a branded acquisition, andKate Spade could be one of the strongest candidates. While other brands are seeing negative comps, pulling back on wholesale exposure or restructuring,Kate Spade continues to grow.

Top 10 Safest Stocks For 2018: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By Chris Lange]

    Biogen Inc. (NASDAQ: BIIB) had its short interest increase to 2.63 million shares from the previous 2.36 million. The stock closed Friday at $305.20, within a 52-week range of $223.02 to $333.65.

  • [By Ben Levisohn]

    Biogen (BIIB) has dropped 2.2% to $286.16 after getting cut to Market Perform from Outperform at Leerink, and to Equal Weight from Overweight at Morgan Stanley.

  • [By WWW.MONEYSHOW.COM]

    Biogen (BIIB)

    Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.

  • [By WWW.THESTREET.COM]

    Breakups have the potential to create a lot of value. Just look at what Biogen (BIIB) did with its hemophilia franchise. Spun out as Bioverativ (BIVV) , shares started trading earlier this year. The stock has climbed some 23% on seemingly no news, Cramer noted.

  • [By George Budwell]

    Shares of theDanish drugmaker Forward Pharma A/S (NASDAQ:FWP) gained 48.2% yesterday as the result of a settlement and licensing deal with Biogen (NASDAQ:BIIB)involving an ongoing patent dispute over the multiple sclerosis drug Tecfidera. Per the terms of the deal, Biogen will fork overa non-refundable$1.25 billion licensing fee, and possibly pay 10% to 20% royalties on Tecfidera’snet sales to Forward starting in 2021.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was Biogen Inc. (NASDAQ: BIIB) which traded down nearly 4% at $329.58. The stocks 52-week range is $244.28 to $348.84. Volume was 1.2 million matching the daily average of 1.2 million shares.

Top 10 Safest Stocks For 2018: Flowers Foods, Inc.(FLO)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Consumers across the nation know Flowers Foods (NYSE:FLO) from its Wonder bread, Tastykake snack cakes, and Nature’s Own bakery brands. Yet the truly novel thing about Flowers is how it has done such a good job of building up a national presence in an industry that is typically dominated by local competition. Coming into Monday’s fourth-quarter financial report, Flowers investors were hoping to see at least some growth in sales and earnings, but the bakery company wasn’t able to deliver the pace of expansion that most shareholders really want to see.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Safest Stocks For 2018: Valhi Inc.(VHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares slipped by 0.61 percent. Meanwhile, top losers in the sector included Valhi, Inc. (NYSE: VHI), down 13 percent, and LSB Industries, Inc. (NYSE: LXU), down 7 percent.

Top 10 Safest Stocks For 2018: Gogo Inc.(GOGO)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small capin-flight WiFi stockGogo Inc (NASDAQ: GOGO) is scheduled for before the market opens onMonday (February 27th). Last summer, American Airlines did a deal with rival ViaSat, Inc (NASDAQ: VSAT) to provide Internet access on about 100 new Boeing jets. To add to the turbulence, Moody’s Investors Service assigned a B3 Corporate Family Rating, a B3-PD Probability of Default Rating and a SGL-2 Speculative Grade Liquidity Rating to Gogo Inc plus assigned a B2 (LGD3) rating to the Company’s $500 senior secured note offering (after a planned sale of $525 millionin junk bonds fell through). The Ratings Action noted:

  • [By Steve Symington]

    Shares of Gogo Inc. (NASDAQ:GOGO) were up 18.3% as of 1:30 p.m. EST Monday after the in-flight connectivity specialist announced stronger-than-expected fourth-quarter 2016 results.

  • [By Lee Jackson]

    Gogo Inc. (NASDAQ: GOGO) had a director purchasing a total of 300,000 shares at $9.69 per share. The total for the purchase was posted at $3 million.Gogo provides communications services to the commercial and business aviation markets in the United States and internationally. Itsstock was trading on Friday at $8.85.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Dan Caplinger]

    Monday started the new week on a positive note, as the stock market once again recovered from early declines to post advances. The Dow Jones Industrials extended its string of record closes to 12 consecutive days in the wake of favorable comments from Warren Buffett about the valuation of the market. Moves within the Trump administration to transfer spending to the Defense Department also bolstered the overall market mood. In addition, good news from certain companies helped to sustain positive sentiment overall, and Advanced Micro Devices (NASDAQ:AMD), Windstream Holdings (NASDAQ:WIN), and Gogo (NASDAQ:GOGO) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    Shares of Gogo Inc (NASDAQ: GOGO) got a boost, shooting up 19 percent to $10.85 after the company reported a narrower-than-expected quarterly loss.

Top 10 Clean Energy Stocks To Watch Right Now

As the sad scenes from Southeast Texas fill TV screens, traders, as always, are taking positions. Oil prices dropped sharply in Monday’s trading and the front-month West Texas Intermediate crude contract is quoted at $46.72 as of this writing.  Sentiment in the oil pits reflects a belief that the damage to Gulf Coast refineries from Hurricane Harvey will cause a general clogging in the system, putting pressure on oil producers. Oil traders’ sentiment is notorious for day-to-day changes, but oil stock traders’ sentiment has been remarkably consistent in 2017: down.

A Sheriff’s boat rescues people after Hurricane Harvey caused heavy flooding in Houston, Texas on August 28, 2017. Rescue teams in boats, trucks and helicopters scrambled Monday to reach hundreds of Texans marooned on flooded streets in and around the city of Houston before monster storm Harvey returns. (MARK RALSTON/AFP/Getty Images)

Top 10 Clean Energy Stocks To Watch Right Now: Rubicon Technology, Inc.(RBCN)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap LED semiconductor stockRubicon Technology (NASDAQ: RBCN):

    Rubicon Technology isn’t going to be a monster-sized winner for us, even if things go perfectly. About the best downside target we could hope for is the $0.60 area, where the stock was launched into an unsustainable uptrend a week ago. But, it’s a high-odds trade we can’t pass up. Yesterday’s doji bar after a big rally was a warning sign that we were transitioning into a net-selling environment. Today’s sharp pullback confirms we’re moving into that bearish mode.

Top 10 Clean Energy Stocks To Watch Right Now: Ameresco, Inc.(AMRC)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenAmeresco Inc(NYSE:AMRC) reported financial and operating results for its fourth quarter and fiscal year 2016 on March 2, the market was ecstatic, pushing shares up more than 17% on a combination of beating analyst expectations for profits, a solid order backlog for future business, and continued optimism around infrastructure investment in coming years.

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

  • [By Lisa Levin]

    Shares of Ameresco Inc (NYSE: AMRC) got a boost, shooting up 16 percent to $6.05 after the company reported strong Q4 results.

    Navigator Holdings Ltd (NYSE: NVGS) shares were also up, gaining 23 percent to $13.50 on better-than-expected quarterly earnings.

Top 10 Clean Energy Stocks To Watch Right Now: Cray Inc(CRAY)

Advisors’ Opinion:

  • [By Giulio Prisco]

    Microsoft (NSDQ:MSFT), supercomputer maker Cray (NSDQ:CRAY), and the Swiss National Supercomputing Centre (CSCS), a world-class scientific computing center, announced the results of a deep learning collaboration that expands the horizons of running Artificial Intelligence (AI), Machine Learning (ML), and in particular Deep Learning (an especially promising branch of ML) applications, using Microsoft software and Cray supercomputers.

  • [By Jim Robertson]

    Cray Inc. (CRAY) has been one of those feast or famine small caps that have either made traders and investors a lot of money in recent years – or simply frustrated those who’ve held it for quite some time. However, at this point we think CRAY offers an attractive risk/reward opportunity on a long-term basis for investors interested in exposure to big data analytics and specifically super-computing – a growing need for large enterprise and institutions all over the world

  • [By Peter Graham]

    The Q4 2016 earnings report for small capsupercomputer stock Cray Inc (NASDAQ: CRAY) is scheduled forafter the market closes onWednesday (February 8th). Back in 2012, Cray Inc was inour SmallCap Network Elite Opportunity (SCN EO) portfolioasa potentially goodlow risk longer-term play as shares were trading at the $12 level and eventually hit $40+ per share before coming back down to earth last year.

  • [By Lisa Levin]

    Tuesday afternoon, the technology sector proved to be a source of strength for the market. Leading the sector was strength from Cray Inc. (NASDAQ: CRAY) and Mellanox Technologies, Ltd. (NASDAQ: MLNX).

Top 10 Clean Energy Stocks To Watch Right Now: Oshkosh Corporation(OSK)

Advisors’ Opinion:

  • [By Rich Smith]

      I first named Oshkosh my top stock pick back in September, when the stock cost $42 and change. Since then, the stock has gone down, and sells for $3 less. So am I supposed to dislike Oshkosh stock now?

    No. To the contrary, I like it even more. (About $3 more, in fact).

    You see, even in the process of picking Oshkosh back then, I warned investors: "I don’t know whether Oshkosh will be the best-performing stock in the world in the month of September, but I’ve got a strong hunch about the next six months." And that hunch remains — because the facts have not changed.

    This past summer, Oshkosh was named the winner of the Pentagon’s contract to build a next-gen "Humvee" — an armored Joint Light Tactical Vehicle that will serve the U.S. military for decades to come. Oshkosh won an initial award to produce 17,000 vehicles for $6.7 billion. Ultimately, though, this is a contract that could swell to $30 billion or more for production, maintenance, and upgrade of approximately 55,000 JLTVs across all military branches.

    So why hasn’t Oshkosh stock moved in response to the contract? Mainly because rival bidderLockheed Martin threw a monkey wrench into the contracts process, first protesting the JLTV award to Oshkosh, and then, when that protest was rejected, filing suit in court to try to win the contract away from its rival.

    Personally, I think Lockheed Martin will lose that suit as well. After all, Lockheed’s forte is in fighter jets, while Oshkosh is the military’s premier supplier of trucks like JLTV, as well as the Army’s M-ATV vehicle (a small, all-terrain MRAP). Perhaps recognizing this, AM General, the other company that bid against Oshkosh on JLTV and lost, declined to protest the award. Lockheed took the other road, but I expect it will be a dead end for Lockheed as well.

  • [By WWW.THESTREET.COM]

    Oshkosh (OSK) was downgraded to neutral from buy at Bank of America/Merrill Lynch. $62 price target. The valuation is less attractive, as the stock is trading at 21x expected 2017 earnings, analysts said. 

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

Top 10 Clean Energy Stocks To Watch Right Now: J.B. Hunt Transport Services Inc.(JBHT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on August 3, 2016.

    J B Hunt Transport Services Inc (NASDAQ: JBHT) – $0.2200 dividend, 1.0791 percent yield
    Johnson Controls Inc (NYSE: JCI) – $0.2900 dividend, 2.6250 percent yield
    FirstEnergy Corp. (NYSE: FE) – $0.3600 dividend, 3.9680 percent yield
    Sunoco LP (NYSE: SUN) – $0.8255 dividend, 10.7347 percent yield
    Wells Fargo & Co (NYSE: WFC) – $0.3800 dividend, 3.1588 percent yield
    BP plc (ADR) (NYSE: BP) – $0.6000 dividend, 6.8768 percent yield
    American Airlines Group Inc (NASDAQ: AAL) – $0.1000 dividend, 1.1442 percent yield
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) – $0.1300 dividend, 2.9834 percent yield
    Alcoa Inc (NYSE: AA) – $0.0300 dividend, 1.1321 percent yield
    Sensient Technologies Corporation (NYSE: SXT) – $0.2700 dividend, 1.5341 percent yield

    Posted-In: Ex-DividendNews Dividends Markets Trading Ideas

Top 10 Clean Energy Stocks To Watch Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

Top 10 Clean Energy Stocks To Watch Right Now: bebe stores, inc.(BEBE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Just in the past few weeks, Wall Street has seen bankruptcy filings from sporting goods retailer Gander Mountain, RadioShack successor General Wireless Operations, everyday value price department store operator Gordmans Stores (GMAN) and appliances, electronics and furniture retailer HHGregg (HGG) . Last Wednesday, children’s apparel retailer Gymboree cautioned it was running low on cash and may not survive. Sears Holdings Corp. (SHLD) voiced concerns on Tuesday about its ability to stay in business, while women’s apparel chain Bebe (BEBE) is reportedly on the brink of closing all 170 of its stores.

  • [By Lisa Levin] Related HTGM 20 Biggest Mid-Day Losers For Thursday 25 Stocks Moving In Thursday's Pre-Market Session HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU (GuruFocus)
    Related SSH 15 Biggest Mid-Day Gainers For Wednesday 12 Biggest Mid-Day Losers For Tuesday Healthcare – Top 5 Gainers / Losers as of 11:00 am (Seeking Alpha) Gainers
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 63.6 percent to $3.50 in pre-market trading after the company disclosed that it has obtained CE marking in the EU for HTG EdgeSeq ALKPlus Assay.
    Sunshine Heart Inc (NASDAQ: SSH) rose 20.3 percent to $2.61 in pre-market trading after the company issued a business update regarding execution of its strategic growth plan.
    bebe stores, inc. (NASDAQ: BEBE) shares rose 11.1 percent to $4.29 in pre-market trading after the company disclosed that it is exploring strategic alternatives.
    Cancer Genetics Inc (NASDAQ: CGIX) rose 10.3 percent to $3.20 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
    Five Below Inc (NASDAQ: FIVE) rose 8.8 percent to $41.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter.
    FireEye Inc (NASDAQ: FEYE) rose 8 percent to $12.40 in pre-market trading. Goldman Sachs upgraded FireEye from Sell to Buy.
    PVH Corp (NYSE: PVH) shares rose 7.4 percent to $97.60 in pre-market trading after the company posted upbeat earnings for its fourth quarter and issued a strong earnings forecast.
    Bitauto Hldg Ltd (ADR) (NASDAQ: BITA) shares rose 7 percent to $26.00 in pre-market trading after dropping 1.30 percent on Wednesday.
    Pingtan Marine Enterprise Ltd (NASDAQ: PME) rose 6.6 percent to $4.50 in pre-market trading after gaining 0.48 pe
  • [By WWW.THESTREET.COM]

    Not helping matters was a continued drumbeat of retail death stories such as Payless possibly closing 500 stores, Bebe (BEBE) on the verge of shuttering 170 stores and Sears Holdings’  (SHLD) CFO spreading #fakenews in a new blog post that the retailer is a “viable” entity. It’s not, especially after the language it slipped in its new annual report on Tuesday. 

  • [By Lisa Levin]

    bebe stores, inc. (NASDAQ: BEBE) shares dropped 26 percent to $3.86. bebe stores will reportedly license www.bebe.com domain name, social media accts. and international wholesale agreements to one or more third parties, according to Reuters.

Top 10 Clean Energy Stocks To Watch Right Now: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Hasbro, Inc largely trending upward while shares of peers like mid cap Mattel, Inc (NASDAQ: MAT) and small cap JAKKS Pacific, Inc (NASDAQ: JAKK) have largely trended downward:

  • [By Peter Graham]

    A long term performance chart shows shares of Hasbro, Inc largely going in one direction while shares of peers likemid cap Mattel, Inc (NASDAQ: MAT)and small cap JAKKS Pacific, Inc (NASDAQ: JAKK) have gone in the other direction:

  • [By Roberto Pedone]

    One under-$10 toy player that’s trending very close to triggering a major breakout trade is Jakks Pacific (JAKK), which is a producer and marketer of children’s toys and other consumer products. This stock has been destroyed by the bears so far in 2013, with shares off sharply by 60%.

    If you take a look at the chart for Jakks Pacific, you’ll notice that this stock has been downtrending badly for the last two months and change, with shares plunging from its high of $11.75 to its recent low of $4.82 a share. During that downtrend, shares of JAKK have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of JAKK look like they might be ready to see an end to its downside volatility in the short-term if the recent lows can hold. I believe this due to the fact that JAKK has started to move sideways and trend within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in JAKK if it manages to break out above some near-term overhead resistance levels at $5.08 to $5.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 695,817 shares. If that breakout triggers soon, then JAKK will set up to re-test or possibly take out its next major overhead resistance levels at $5.68 to its 50-day moving average at $6.07 a share. Any high-volume move above its 50-day will then put $7 to $8 into range for shares of JAKK.

    Traders can look to buy JAKK off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.87 to $4.82 a share. One can also buy JAKK off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Clean Energy Stocks To Watch Right Now: Mitsubishi Corporation (MSBHY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Automotive is moving well, up 14% y/y driven by HD Radio tech. The latter is included in an A list of important models, including Tesla Model 3, the Mitsubishi (OTCPK:MSBHY) Mirage and the Nissan (OTCPK:NSANY) Rogue. Their connected radio solution is also coming along nicely.

  • [By SEEKINGALPHA.COM]

    Mitsubishi (OTCPK:MSBHY)

    Earlier in 2016, Mitsubishi released its 2017 i-MiEV. It is fully electric, with a 16 kWh lithium-ion battery pack and a range of 62 miles. Basically just a short trips car, as the range is really very low. Mitsubishi also has its popular plug in hybrid Outlander model that sells quite well. As stated last month, the company announced “plans to launch a compact EV with 250-mile range by 2020”. Mitsubishi is currently ranked 7th in global EV sales.

  • [By SEEKINGALPHA.COM]

    Renault Nissan (OTC:RNSDF) (NSANY)/Mitsubishi (OTCPK:MSBHY) (MMTOF)

    On December 20, Green Car Reports reported: “Mitsubishi electric cars to use Nissan-Renault platforms.” Remember Mitsubishi has the US$22,995 all-electric 16 kWh iMiEV coming out in 2017.

Top 10 Clean Energy Stocks To Watch Right Now: Tesla Motors, Inc.(TSLA)

Advisors’ Opinion:

  • [By Kumar Abhishek]

    Tesla Inc(NASDAQ:TSLA) yesterday reported its Q4 and FY 2016 earnings. ThePalo Alto, California, based company was reporting its first earnings after the $2 billion acquisition of renewable energy company SolarCity (NASDAQ:SCTY). Tesla reported a wider than expected loss but a beat on revenues.The electric car maker said it lost 69 cents a share against analyst estimates of a loss of 53 cents a share. On the revenue front, the company reported $2.29 billion in revenues. Analysts were looking for a revenue of $2.19 billion. Theresponse of Tesla stock to the earnings was comparatively muted. Tesla stock gained by around 1.5% in the after hours. The movement in the stock was much lower than many were expecting. Tesla options had priced in a movement of 6% in either direction (which was higher than usual 5% move).

  • [By WWW.THESTREET.COM]

    A number of executives that have advocated staying in the Paris agreement and fighting climate change have also taken part in meetings and business councils with Trump. Tesla (TSLA) CEO Elon Musk said on Twitter on Wednesday that he will “have no choice but to depart” any Trump advisory councils if the president scraps the Paris agreement. He had previously defended his decision to meet with Trump as a chance to argue in favor of immigration and climate change policy but acknowledged “maybe nothing will happen.”

  • [By Daniel Sparks]

    While Tesla’s (NASDAQ:TSLA) fourth-quarter earnings release a few weeks ago included a handful of nuggets for investors, including the company’s current financial situation and management’s guidance for vehicle sales and capital spending in the first half of the year, Tesla’s lengthy earnings call arguably boasted some of the most important updates on the company.

  • [By Benzinga News Desk]

    Tesla Motors Inc (NASDAQ: TSLA) and Panasonic Corporation (ADR) (OTCMKTS:PCRFY) are set to begin manufacturing solar panels in Buffalo, New York. [Bloomberg] 

investment funds

If there is such a thing as an investing rut, I often worry that I’m in one. As a relatively new investor, I max out my IRA every year, but that’s about all I do. There is no second tier to my investing process, so I have been trying to learn more about other means of investing in hopes that I will invest more, or at least strengthen my current investments in the new year.

I think a lot of young professionals are unsure of where to put their money beyond the 401(k). If you’re someone who has resolved to become a better investor in 2017, here are some starter tips. To help guide these tips, I spoke with investment expert Hans Scheil, who is the president of North Carolina-based Cardinal Retirement Planning, Inc., and the author of The Complete Cardinal Guide to Planning for and Living in Retirement. A 40-year veteran in the financial services industry, he works to help investors create a diverse and stable investment portfolio.

1. You should only invest beyond your 401(k) and IRA if you are already contributing as much as you are allowed to.

investment funds: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    StarBulk Carriers (SBLK) and Safe Bulkers (SB) have more than tripled during the past 12 months, while Golden Ocean Group (GOGL) has more than doubled. So it must be time for an upgrade right?

  • [By Elizabeth Balboa]

    Meanwhile, Safe Bulkers, Inc. (NYSE: SB) rose $0.73 throughout the 2016, Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) fell $1.69 and Navios Maritime Partners L.P. (NYSE: NMM) dropped $0.93.

investment funds: Gladstone Land Corporation(LAND)

Advisors’ Opinion:

  • [By Cameron Swinehart]

    Gladstone Land Corp (LAND) –

    A U.S. based farmland investment company that currently offers a plus 9% annual distribution. It owns and leases farmland in Florida, California, Michigan and Oregon with appraised land value of $79 million. The distribution is paid monthly which should attract income investors.

investment funds: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Spark Therapeutics Inc. (NASDAQ: ONCE) dropped 44% Monday to post a new 52-week low of $41.06 after closing at $73.38 on Friday. The 52-week high is $91.75. Volume was around 13.5 million, nearly 30 times the daily average of about 480,000. The company’s hemophilia A drug posted disappointing trial results.

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

  • [By Lisa Levin]

    Shares of Spark Therapeutics Inc (NASDAQ: ONCE) were down 36 percent to $47.08 on preliminary SPK-8011 trial data.

    Athenex Inc (NASDAQ: ATNX) was down, falling around 13 percent to $13.95. Almirall and Athenex reported a strategic partnership to develop and commercialize KX2-391 in the U.S. and Europe.

  • [By Chris Lange]

    Spark Therapeutics Inc. (NASDAQ: ONCE) saw its shares take a big step back on Monday after the firm reported less than favorable results at the American Society of Hematology (ASH) annual meeting. Analysts have taken this opportunity to weigh in on the stock:

investment funds: Cowen Group, Inc.(COWN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cowen Group Inc (NASDAQ: COWN) shares were also up, gaining 17 percent to $15.80 after the company posted upbeat Q1 earnings.

    Equities Trading DOWN

investment funds: Swedish Export Credit Corp (GRU)

Advisors’ Opinion:

  • [By Casey Wilson]

    Investing in commodity-based ETFs (exchange-traded funds) or ETNs (exchange-traded notes) is a great way to gain exposure to a specific commodity, like corn (NYSE Arca: CORN), livestock (NYSE Arca: COW), or grains (NYSE Arca: GRU).